Why Did the FDA Issue A New COVID Drug Emergency Use Authorization in April 2023?
In April 2023, the FDA gave EUA for a new drug to be used for covid 19 patients who were intubated or on ECMO. First off, why is this under EUA when the pandemic emergency was declared over in May? Why would they approve this just a month before?
Several other people speculate this is replacing Remdesivir or Veklury. Why are they only giving this monoclonal antibody to the most severely ill? It is being deployed exactly like Remdesivir was……in “severely ill ventilated patients”. At the bottom of the link above is the EUA that was given this spring prior to the expiration of the covid emergency.
How do you “sneak one in”? This is how. It is IV dosed, must be started within 48 hours of mechanical ventilation or ECMO. Also, the DRUG IS NOT APPROVED FOR USE, it is only granted EUA. Smells like every other covid treatment that has failed. Is it as deadly as Remdesivir? We don’t know yet.
No comments:
Post a Comment